-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Downgrades Biohaven to Neutral, Lowers Price Target to $11

Benzinga·12/03/2025 12:11:50
语音播报
HC Wainwright & Co. analyst Douglas Tsao downgrades Biohaven (NYSE:BHVN) from Buy to Neutral and lowers the price target from $30 to $11.